144 related articles for article (PubMed ID: 34484361)
1. Unresectable bulky chest wall recurrent breast cancer controlled with CT-guided interstitial high-dose-rate brachytherapy and external beam radiotherapy with adjuvant hormonal therapy - case report.
Kunogi H; Hsu IC; Sasai K
J Contemp Brachytherapy; 2021 Aug; 13(4):451-457. PubMed ID: 34484361
[TBL] [Abstract][Full Text] [Related]
2. High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.
Shimizu Y; Murakami N; Chiba T; Kaneda T; Okamoto H; Nakamura S; Takahashi A; Kashihara T; Takahashi K; Inaba K; Okuma K; Nakayama Y; Itami J; Igaki H
Front Oncol; 2021; 11():808721. PubMed ID: 35155202
[TBL] [Abstract][Full Text] [Related]
3. Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.
Murakami N; Kasamatsu T; Sumi M; Yoshimura R; Harada K; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Itami J
Radiat Oncol; 2014 Jan; 9():31. PubMed ID: 24456669
[TBL] [Abstract][Full Text] [Related]
4. Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost.
Thibault I; Lavallée MC; Aubin S; Jain S; Laflamme N; Vigneault É
Brachytherapy; 2013; 12(5):500-7. PubMed ID: 23406985
[TBL] [Abstract][Full Text] [Related]
5. Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer.
Yoshida K; Yamazaki H; Kotsuma T; Takenaka T; Masui K; Yoshioka Y; Uesugi Y; Shimbo T; Yoshikawa N; Yoshioka H; Narumi Y; Tatsumi K; Tanaka E
Brachytherapy; 2015; 14(4):440-8. PubMed ID: 25858904
[TBL] [Abstract][Full Text] [Related]
6. Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report.
Johnson SB; Prisciandaro JI; Zhou J; Hadley SW; Reynolds RK; Jolly S
J Appl Clin Med Phys; 2014 Jan; 15(1):4520. PubMed ID: 24423851
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
8. Fibre-optic endoscope-guided three-dimensional high-dose-rate interstitial brachytherapy for residual nasopharyngeal carcinoma after conventional external beam radiotherapy.
Zhang X; Wu N; Zhao Z; Han D; He M; Yang W; Cheng G
J Contemp Brachytherapy; 2019 Jun; 11(3):243-249. PubMed ID: 31435431
[TBL] [Abstract][Full Text] [Related]
9. Biological dose summation of external beam radiotherapy for the whole breast and image-guided high-dose-rate interstitial brachytherapy boost in early-stage breast cancer.
Fröhlich G; Mészáros N; Smanykó V; Polgár C; Major T
J Contemp Brachytherapy; 2020 Oct; 12(5):462-469. PubMed ID: 33299435
[TBL] [Abstract][Full Text] [Related]
10. A case report of a patient with bulky uterine cervical neoplasm who achieved complete response with "intentional internal high-dose policy" high-dose-rate interstitial brachytherapy.
Kashihara T; Kobayashi K; Iijima K; Murakami N; Yoshida K; Okuma K; Nakamura S; Takahashi K; Inaba K; Igaki H; Nakayama Y; Kato T; Uno T; Itami J
Medicine (Baltimore); 2020 Jul; 99(27):e20860. PubMed ID: 32629674
[TBL] [Abstract][Full Text] [Related]
11. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
12. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience.
D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K
Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570
[TBL] [Abstract][Full Text] [Related]
13. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
Lee YC; Rash DL; Stern RL; Mayadev JS
Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
[TBL] [Abstract][Full Text] [Related]
14. Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer.
Wang X; Li J; Wang P; Yuan K; Yin G; Wan B
J Contemp Brachytherapy; 2016 Apr; 8(2):122-7. PubMed ID: 27257416
[TBL] [Abstract][Full Text] [Related]
15. Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy.
Murofushi KN; Ishida T; Baba K; Kawakita K; Sasaki TS; Okumura T; Sato T; Sakurai H
J Contemp Brachytherapy; 2021 Feb; 13(1):32-38. PubMed ID: 34025734
[TBL] [Abstract][Full Text] [Related]
16. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
18. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery.
Kotsuma T; Yoshida K; Yamazaki H; Takenaka T; Konishi K; Isohashi F; Koizumi M; Tanaka E; Yoshioka Y
J Radiat Res; 2011; 52(3):329-34. PubMed ID: 21467737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
